2013
DOI: 10.1073/pnas.1301738110 View full text |Buy / Rent full text
|
|

Abstract: The clinical severity of the neurodegenerative disorder spinal muscular atrophy (SMA) is dependent on the levels of functional Survival Motor Neuron (SMN) protein. Consequently, current strategies for developing treatments for SMA generally focus on augmenting SMN levels. To identify additional potential therapeutic avenues and achieve a greater understanding of SMN, we applied in vivo, in vitro, and in silico approaches to identify genetic and biochemical interactors of the Drosophila SMN homolog. We identifi… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
1
35
0

Publication Types

Select...

Relationship

0
0

Authors

Journals